Home > Insider Trading > Filing (0001209191-18-033073)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1610618	Cidara Therapeutics Inc.	CDTX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1478831	Jeffrey Stein	6310 Nancy Ridge Drive Suite 101 San Diego CA 92121	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-05-23	212,766	$4.70	268,320	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant (right to buy)	Acquisiton	2018-05-23	250,000	$0.13	250,000	$6.81

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
250,000	2018-05-23		No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	203,697	Indirect	By trust
Common Stock	420	Indirect	By son

Footnotes

Shares were purchased in a registered direct offering pursuant to a Subscription Agreement dated May 21, 2018.
Includes 3,703 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 18, 2018.
The Warrants will expire upon the earliest of (i) May 23, 2023, (ii) the date that the holder of such Warrant transfers or sells any of the shares of Common Stock purchased by such holder in the first closing of the offering (i.e. May 23, 2018), if such transfer or sale occurs prior to the date that is 120 calendar days following May 23, 2018, (iii) the taking of any short position on the Common Stock by the holder of such Warrant prior to the completion of the second closing of the offering, to be determined, and (iv) the failure by the holder of such Warrant to purchase its pro rata allocation of shares of Common Stock in the second closing of the offering, to be determined.